BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
Wellteq Launches Beta Production of Internet of Medical Things HealthHub with API as a Service Biotech Investing
BLU Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Biotech Investing
Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes Biotech Investing
Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021 Biotech Investing
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Biotech Investing
